Benzinga's Top Pre-Market Gainers

by Lisa Levin, Benzinga Editor

November 12, 2012 8:13 AM | 1 min read | Make a Comment

Celgene

CELGZ

moved up 100.84% to $6.25 in the pre-market session. Celgene's pancreatic cancer drug Abraxene improved overall survival rates in a phase III study. Titanium Metals

TIE

surged 42.61% to $16.50 in the pre-market session. Precision Castparts

PCP

announced its plans to acquire Titanium Metals for around $2.9 billion. Jefferies Group

JEF

added 20.51% to $17.16 in the pre-market session. Leucadia National

LUK

announced its plans to acquire Jefferies Group. Gilead Sciences

GILD

soared 9.77% to $71.36 in the pre-market trading. Gilead Sciences announced positive results in mid-stage hepatitis C virus (HCV) infection study.

Market News and Data brought to you by Benzinga APIs

Posted In: News Pre-Market Outlook Markets Movers Financials Multi-Sector Holdings Top Pre-Market Gainers

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!